NorthWest Biotherapeutics Inc (NWBO)

[OncoJock]

I'm Counting 19 Fewer Authors Than in 2018.

Thank you so much, CrashOverride, this is an awesome contribution to our collective due diligence.

I counted 50 names here, and I counted 69 names in the list of authors in the 2018 article in Journal of Translational Medicine reporting preliminary results of the phase 3 trial.

I'm wondering what, if anything, that may mean?

I'm also noticing that Dr. Steven Brem has moved up the list considerably, from 29th place in 2018 to 3rd place today.

Again, does anyone have any idea what this may mean? I'm interested because I live outside Philadelphia and the University of Pennsylvania (where Dr. Brem works) is one of my favorite schools.

It also may mean this story (when it finally breaks) may be picked up by our hometown newspaper, the Philadelphia Inquirer.